CO5251460A1 - Diazepanes, proceso para su preparacion y composicion farmaceutica que los contiene - Google Patents
Diazepanes, proceso para su preparacion y composicion farmaceutica que los contieneInfo
- Publication number
- CO5251460A1 CO5251460A1 CO00077443A CO00077443A CO5251460A1 CO 5251460 A1 CO5251460 A1 CO 5251460A1 CO 00077443 A CO00077443 A CO 00077443A CO 00077443 A CO00077443 A CO 00077443A CO 5251460 A1 CO5251460 A1 CO 5251460A1
- Authority
- CO
- Colombia
- Prior art keywords
- carbon atoms
- alkyl
- amino
- optionally substituted
- arylalkyl
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 150000000117 diazepanes Chemical class 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 14
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- -1 amino, amino Chemical group 0.000 abstract 4
- 125000003118 aryl group Chemical group 0.000 abstract 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 3
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 3
- 229910052799 carbon Inorganic materials 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical group C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical group 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- 235000010290 biphenyl Nutrition 0.000 abstract 1
- 239000004305 biphenyl Substances 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000006289 hydroxybenzyl group Chemical group 0.000 abstract 1
- 125000006301 indolyl methyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Transplantation (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
Abstract
La presente invención se relaciona con un compuesto de la fórmula l:<EMI FILE="00077443_1" ID="1" IMF=JPEG >en donde:n es1, 2, ó 3, R1 es H, alquilo de 1 a 4 átomos de carbono; arilo; o arilalquilo de 1 a 4 átomos de carbono;Y es alquileno de 1 a 4 átomos de carbono; -CO-C-alquileno de 1 a 4 átomos de carbono; -CO-C-alquenileno de 2 a 5 átomos de carbono; -CO-NH-; -CO-C-alquileno de 1 a 3 átomos de carbono-NH-; ó -CO-O-,R2 es un residuo aromático o heteroaromático, cada uno opcionalmente sustituido por CF3, halógeno, OH, alcoxilo de 1 a 4 átomos de carbono, amino, amino sustituido por mono- o di-alquilo de 1 a 4 átomos de carbono, fenilo, bencilo, o alquilo de 1 a 4 átomos de carbono opcionalmente sustituido por amino,R3 es la cadena lateral presente sobre el Ca de un a-aminoácido,R4 es bifenililo; o bencilo, hidroxibencilo, a - ó ß-naf-tilmetilo, 5,6,7,8-tetrahidro-ß-naftilmetilo, o indolilmetilo, cada uno opcionalmente sustituido sobre el anillo por CF3, halógeno, OH, alcoxilo de 1 a 4 átomos de carbono, amino, amino sustituido por mono- o di-alquilo de 1 a 4 átomos de carbono, fenilo, bencilo, o alquilo de 1 a 4 átomos de carbono opcionalmente sustituido por amino, yX es -CN; -NR5R6; u -O-R8, en donde R5 es H, alquilo de 1 a 6 átomos de carbono, arilo, o arilalquilo de 1 a 4 átomos de carbono, R6 es H ó alquilo de 1 a 6 átomos de carbono, y R8 es H, alquilo de 1 a 4 átomos de carbono, arilo, o arilalquilo de 1 a 4 átomos de carbono, en forma libre o en forma de sal. Igualmente, se refiere al proceso para la preparación de dicho compuesto y a composiciones farmacéuticas que lo contienen.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41681599A | 1999-10-13 | 1999-10-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5251460A1 true CO5251460A1 (es) | 2003-02-28 |
Family
ID=23651420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO00077443A CO5251460A1 (es) | 1999-10-13 | 2000-10-11 | Diazepanes, proceso para su preparacion y composicion farmaceutica que los contiene |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1220852B1 (es) |
| JP (1) | JP3889623B2 (es) |
| AT (1) | ATE316084T1 (es) |
| AU (1) | AU7918500A (es) |
| CO (1) | CO5251460A1 (es) |
| CY (1) | CY1105020T1 (es) |
| DE (1) | DE60025639T2 (es) |
| DK (1) | DK1220852T3 (es) |
| EC (1) | ECSP003707A (es) |
| ES (1) | ES2257328T3 (es) |
| PE (1) | PE20010745A1 (es) |
| WO (1) | WO2001027102A1 (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6110922A (en) | 1998-12-29 | 2000-08-29 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| CA2414461A1 (en) | 2000-06-29 | 2002-01-10 | Abbott Laboratories | Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| US6521619B2 (en) | 2000-06-29 | 2003-02-18 | Icos Corporation | Aryl phenylcyclopropyl sulfide derivatives and their use as cell adhesion inhibiting anti-inflammatory and immune suppressive agents |
| PE20020420A1 (es) | 2000-10-02 | 2002-06-27 | Novartis Ag | Derivados de diazacicloalcanodiona como antagonistas del antigeno asociado a la funcion del linfocito-1 (lfa-1) |
| GB0301561D0 (en) * | 2003-01-23 | 2003-02-26 | Novartis Ag | Organic compounds |
| TWI311557B (en) * | 2003-01-23 | 2009-07-01 | Novartis A | Pharmaceutically active diazepanes |
| PL1682537T3 (pl) | 2003-11-05 | 2012-09-28 | Sarcode Bioscience Inc | Modulatory adhezji komórkowej |
| WO2007054128A1 (en) * | 2005-11-14 | 2007-05-18 | Dominion Pharmakine S.L. | Novel inhibitors of the lfa-1/icam-1 interaction, and uses thereof |
| GB0507918D0 (en) * | 2005-04-19 | 2005-05-25 | Novartis Ag | Organic compounds |
| CA2609053C (en) | 2005-05-17 | 2017-04-25 | Sarcode Corporation | Compositions and methods for treatment of eye disorders |
| EP3797775A1 (en) | 2007-10-19 | 2021-03-31 | Novartis AG | Compositions and methods for treatment of diabetic retinopathy |
| US8080562B2 (en) | 2008-04-15 | 2011-12-20 | Sarcode Bioscience Inc. | Crystalline pharmaceutical and methods of preparation and use thereof |
| US8378105B2 (en) | 2009-10-21 | 2013-02-19 | Sarcode Bioscience Inc. | Crystalline pharmaceutical and methods of preparation and use thereof |
| GB201016864D0 (en) | 2010-10-06 | 2010-11-17 | Univ Aston | Therapeutic methods |
| CN104797574B (zh) | 2012-07-25 | 2019-11-22 | 原生质生物科学股份有限公司 | Lfa-1抑制剂及其多晶型物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL92011A0 (en) * | 1988-10-19 | 1990-07-12 | Abbott Lab | Heterocyclic peptide renin inhibitors |
| PL294870A1 (es) * | 1991-06-21 | 1993-02-08 | Hoechst Ag | |
| WO1999020618A1 (en) * | 1997-10-21 | 1999-04-29 | Active Biotech Ab | Thiadiazoles amides useful as antiinflammatory agents |
-
2000
- 2000-10-10 EC EC2000003707A patent/ECSP003707A/es unknown
- 2000-10-11 AT AT00969490T patent/ATE316084T1/de not_active IP Right Cessation
- 2000-10-11 AU AU79185/00A patent/AU7918500A/en not_active Abandoned
- 2000-10-11 CO CO00077443A patent/CO5251460A1/es not_active Application Discontinuation
- 2000-10-11 ES ES00969490T patent/ES2257328T3/es not_active Expired - Lifetime
- 2000-10-11 DK DK00969490T patent/DK1220852T3/da active
- 2000-10-11 PE PE2000001087A patent/PE20010745A1/es not_active Application Discontinuation
- 2000-10-11 JP JP2001530320A patent/JP3889623B2/ja not_active Expired - Fee Related
- 2000-10-11 EP EP00969490A patent/EP1220852B1/en not_active Expired - Lifetime
- 2000-10-11 DE DE60025639T patent/DE60025639T2/de not_active Expired - Lifetime
- 2000-10-11 WO PCT/EP2000/010025 patent/WO2001027102A1/en active IP Right Grant
-
2006
- 2006-04-13 CY CY20061100521T patent/CY1105020T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PE20010745A1 (es) | 2001-07-17 |
| CY1105020T1 (el) | 2010-03-03 |
| DE60025639D1 (de) | 2006-04-06 |
| EP1220852A1 (en) | 2002-07-10 |
| WO2001027102A1 (en) | 2001-04-19 |
| ECSP003707A (es) | 2002-05-23 |
| DE60025639T2 (de) | 2006-11-16 |
| EP1220852B1 (en) | 2006-01-18 |
| ES2257328T3 (es) | 2006-08-01 |
| DK1220852T3 (da) | 2006-05-15 |
| ATE316084T1 (de) | 2006-02-15 |
| JP3889623B2 (ja) | 2007-03-07 |
| AU7918500A (en) | 2001-04-23 |
| JP2003511447A (ja) | 2003-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5251460A1 (es) | Diazepanes, proceso para su preparacion y composicion farmaceutica que los contiene | |
| TW200619191A (en) | Phenyl compounds with more than 2 substitutes | |
| ECSP066405A (es) | Compuestos de aril o heteroaril amida | |
| CO4820431A1 (es) | Compuestos calciliticos habiles para inhibir la actividad receptora de calcio, composisicon farmaceutica y metodo de utilizacion | |
| AR040031A1 (es) | Compuestos de pirazol-pirimidina anilina utiles como inhibidores de cinasa y composiciones farmaceuticas que los contienen | |
| CO5150173A1 (es) | Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv | |
| AR004735A1 (es) | Quinoleina 4-amido sustituida, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso de los mismos para lapreparacion de un medicamento. | |
| ID28740A (id) | SENYAWA-SENYAWA SEFEM YANG MENGANDUNG IMIDAZO [4,5-b] PIRIDINIUMMETIL YANG MEMPUNYAI SPEKTRUM ANTIBAKTERI YANG LUAS | |
| TW430664B (en) | Substituted carboxamidothiazoles, their preparation and pharmaceutical compositions containing them | |
| CO6241190A2 (es) | Compuestos para inhibicion enzimatica | |
| AR004972A1 (es) | Compuesto quinolino 4-carboxamidas n-sustituidas, un procedimiento para su preparacion, el uso de los mismos para la fabricacion de un medicamento, una composicion farmaceutica y un antagonista nk-2/nk-3 combinado. | |
| AR067105A1 (es) | Moleculas pequenas que contienen boro | |
| MY145663A (en) | Heterocyclic compounds containing nitrogen as a fuel additive in order to reduce abrasion | |
| AR049385A1 (es) | Sulfoniletil fosforodiamidatos | |
| JP2004505984A5 (es) | ||
| PH12015501098A1 (en) | Antituberculous composition comprising oxazole compounds | |
| BR0210285A (pt) | Utilização de um composto, composto e composição farmacêutica | |
| FI935801A (fi) | Imidatsoliyhdisteitä, niiden valmistus ja käyttö | |
| CY1105459T1 (el) | Συνθεσεις που πepιεχουν εποθιλονες και η χρηση τους για τη θepαπεια του καρκινοειδους συνδρομου | |
| AR037940A1 (es) | Compuestos antivirales de piridoquinoxalina | |
| TR200200360T2 (tr) | Antibakteriyel aktif maddeler. | |
| AR015514A1 (es) | Compuesto de amida, proceso para su preparacion y composicion farmaceutica que lo contiene | |
| BR0213731A (pt) | Compostos de silìcio | |
| EP0303546A3 (en) | O-alkylation process for n-(hydroxy)aralkyl phenyl ethanol amines | |
| TW200745048A (en) | Novel benzimidazole and benzothiazole derivatives, preparation process therefor, application thereof as medicaments, pharmaceutical compositions and novel use especially as CMET inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Application withdrawn |